89
Views
5
CrossRef citations to date
0
Altmetric
Review

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes

, &
Pages 43-54 | Published online: 17 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stephen Melnick, Priya Rajagopalan, Theresa Lynn & Anthony Donato. (2018) Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use. Journal of Community Hospital Internal Medicine Perspectives 8:5, pages 315-316.
Read now

Articles from other publishers (4)

Mohit Chandrashekar, Stuart Philip, Alexander Nesbitt, Andre Joshi & Marlon Perera. (2021) Sodium glucose‐linked transport protein 2 inhibitors: An overview of genitourinary and perioperative implications. International Journal of Urology 28:10, pages 984-990.
Crossref
Vivencio Barrios & Carlos Escobar. (2021) Canagliflozin: metabolic, cardiovascular and renal protection. Future Cardiology 17:3, pages 443-458.
Crossref
Zhong-Xia Lu, Wen-Jun Xu, Yang-Sheng Wu, Chang-Yu Li & Yi-Tao Chen. (2018) Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay. Journal of Diabetes Research 2018, pages 1-9.
Crossref
Jagriti Upadhyay, Stergios A. Polyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula A. Paschou, Niki Katsiki, Patricia Underwood, Kyung-Hee Park, Jochen Seufert, Eun Seok Kang, Elliot Sternthal, Asterios Karagiannis & Christos S. Mantzoros. (2018) Pharmacotherapy of type 2 diabetes: An update. Metabolism 78, pages 13-42.
Crossref